Publication bias overstates effectiveness of SRIs for autism

04/23/2012 | Huffington Post, The

A review of 10 randomized, double-blind, controlled trials on the effectiveness of serotonin reuptake inhibitors for treating repetitive behaviors in autism showed a publication bias overstating the drug's benefits. Published trials found that the drug yielded small improvements in patients with autism, but after taking into account unpublished trials, the improvement lost its significance, researchers reported in the journal Pediatrics.

View Full Article in:

Huffington Post, The

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Business Development Analyst
Insight Education Group
Los Angeles, CA
Marketing Manager
Insight Education Group
Washington, DC or Los Angeles, CA
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Account Executive
Multiple Locations, SL_Multiple Locations
Professional Development (PD) Staff Trainer
Multiple Locations, SL_Multiple Locations